Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Zinman, B
   PPAR gamma agonists in type 2 diabetes: how far have we come in 'preventing the inevitable'? A review of the metabolic effects of rosiglitazone
   DIABETES OBESITY & METABOLISM
   
   B. Zinman, "PPAR gamma agonists in type 2 diabetes: how far have we come in 'preventing the inevitable'? A review of the metabolic effects of rosiglitazone", DIABET OB M, 3, 2001, pp. S34-S43
2. Moghetti, P
   Advances in the treatment of polycystic ovary syndrome
   EXPERT OPINION ON INVESTIGATIONAL DRUGS
   
   P. Moghetti, "Advances in the treatment of polycystic ovary syndrome", EXPERT OP I, 10(9), 2001, pp. 1631-1640
3. Kaplan, F; Al-Majali, K; Betteridge, DJ
   PPARs, insulin resistance and type 2 diabetes
   JOURNAL OF CARDIOVASCULAR RISK
   
   F. Kaplan et al., "PPARs, insulin resistance and type 2 diabetes", J CARD RISK, 8(4), 2001, pp. 211-217
4. Scheen, AJ
   Thiazolidinediones and liver toxicity
   DIABETES & METABOLISM
   
   A.J. Scheen, "Thiazolidinediones and liver toxicity", DIABETE MET, 27(3), 2001, pp. 305-313
5. Bringer, J; Raingeard, I; Renard, E; Grigorescu, F; Lefebvre, P
   Insulin sensitivity and polycystic ovarian syndrome
   DIABETES & METABOLISM
   
   J. Bringer et al., "Insulin sensitivity and polycystic ovarian syndrome", DIABETE MET, 27(2), 2001, pp. 239-245
6. Reaven, GM
   Insulin resistance: why is it important to treat?
   DIABETES & METABOLISM
   
   G.M. Reaven, "Insulin resistance: why is it important to treat?", DIABETE MET, 27(2), 2001, pp. 247-253
7. Blickle, JF
   Thiazolidinediones: clinical data and perspectives
   DIABETES & METABOLISM
   
   J.F. Blickle, "Thiazolidinediones: clinical data and perspectives", DIABETE MET, 27(2), 2001, pp. 279-285
8. Halimi, S
   Type 2 diabetes mellitus: Which place for thiazolidinediones in the therapeutic strategy?
   DIABETES & METABOLISM
   
   S. Halimi, "Type 2 diabetes mellitus: Which place for thiazolidinediones in the therapeutic strategy?", DIABETE MET, 27(2), 2001, pp. 287-293
9. Peters, AL
   Using thiazolidinediones: Rosiglitazone and pioglitazone in clinical practice
   AMERICAN JOURNAL OF MANAGED CARE
   
   A.L. Peters, "Using thiazolidinediones: Rosiglitazone and pioglitazone in clinical practice", AM J M CARE, 7(3), 2001, pp. S87-S95
10. Inoue, M; Itoh, H; Tanaka, T; Chun, TH; Doi, K; Fukunaga, Y; Sawada, N; Yamshita, J; Masatsugu, K; Saito, T; Sakaguchi, S; Sone, M; Yamahara, K; Yurugi, T; Nakao, K
    Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    M. Inoue et al., "Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma", ART THROM V, 21(4), 2001, pp. 560-566
11. de Dios, ST; Hannan, KM; Dilley, RJ; Hill, MA; Little, PJ
    Troglitazone, but not rosiglitazone, inhibits Na/H exchange activity and proliferation of macrovascular endothelial cells
    JOURNAL OF DIABETES AND ITS COMPLICATIONS
    
    S.T. de Dios et al., "Troglitazone, but not rosiglitazone, inhibits Na/H exchange activity and proliferation of macrovascular endothelial cells", J DIABET C, 15(3), 2001, pp. 120-127
12. Glueck, CJ; Wang, P; Fontaine, R; Tracy, T; Sieve-Smith, L
    Metformin to restore normal menses in oligo-amenorrheic teenage girls withpolycystic ovary syndrome (PCOS)
    JOURNAL OF ADOLESCENT HEALTH
    
    C.J. Glueck et al., "Metformin to restore normal menses in oligo-amenorrheic teenage girls withpolycystic ovary syndrome (PCOS)", J ADOLES H, 29(3), 2001, pp. 160-169
13. Rovin, BH; Lu, L; Cosio, A
    Cyclopentenone prostaglandins inhibit cytokine-induced NF-kappa B activation and chemokine production by human mesangial cells
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    
    B.H. Rovin et al., "Cyclopentenone prostaglandins inhibit cytokine-induced NF-kappa B activation and chemokine production by human mesangial cells", J AM S NEPH, 12(8), 2001, pp. 1659-1667
14. Grinspoon, S
    Insulin resistance in the HIV-lipodystrophy syndrome
    TRENDS IN ENDOCRINOLOGY AND METABOLISM
    
    S. Grinspoon, "Insulin resistance in the HIV-lipodystrophy syndrome", TRENDS ENDO, 12(9), 2001, pp. 413
15. Muto, S; Miyata, Y; Imai, M; Asano, Y
    Troglitazone stimulates basolateral rheogenic Na+/HCO3- cotransport activity in rabbit proximal straight tubules
    EXPERIMENTAL NEPHROLOGY
    
    S. Muto et al., "Troglitazone stimulates basolateral rheogenic Na+/HCO3- cotransport activity in rabbit proximal straight tubules", EXP NEPHROL, 9(3), 2001, pp. 191-197
16. Moore, KJ; Fitzgerald, ML; Freeman, MW
    Peroxisome proliferator-activated receptors in macrophage biology: friend or foe?
    CURRENT OPINION IN LIPIDOLOGY
    
    K.J. Moore et al., "Peroxisome proliferator-activated receptors in macrophage biology: friend or foe?", CURR OP LIP, 12(5), 2001, pp. 519-527
17. Rosenblatt, S; Miskin, B; Glazer, NB; Prince, MJ; Robertson, KE
    The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus
    CORONARY ARTERY DISEASE
    
    S. Rosenblatt et al., "The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus", CORON ART D, 12(5), 2001, pp. 413-423
18. Levine, RA; Sobel, BE
    Insulinoma, type 2 diabetes and plasminogen activator inhibitor type-I
    CORONARY ARTERY DISEASE
    
    R.A. Levine e B.E. Sobel, "Insulinoma, type 2 diabetes and plasminogen activator inhibitor type-I", CORON ART D, 12(4), 2001, pp. 333-336
19. Gouni-Berthold, I; Berthold, HK; Weber, AA; Seul, C; Vetter, H; Sachinidis, A
    Troglitazone and rosiglitazone inhibit the low density lipoprotein-inducedvascular smooth muscle cell growth
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    
    I. Gouni-Berthold et al., "Troglitazone and rosiglitazone inhibit the low density lipoprotein-inducedvascular smooth muscle cell growth", EXP CL E D, 109(4), 2001, pp. 203-209
20. Chen, CC; Wang, HJ; Shih, HC; Sheen, LY; Chang, CT; Chen, RH; Wang, TY
    Comparison of the metabolic effects of metformin and troglitazone on fructose-induced insulin resistance in male Sprague-Dawley rats
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
    
    C.C. Chen et al., "Comparison of the metabolic effects of metformin and troglitazone on fructose-induced insulin resistance in male Sprague-Dawley rats", J FORMOS ME, 100(3), 2001, pp. 176-180
21. Sugawara, A; Takeuchi, K; Uruno, A; Ikeda, Y; Arima, S; Sato, K; Kudo, M; Taniyama, Y; Ito, S
    Differential effects among thiazolidinediones on the transcription of thromboxane receptor and angiotensin II type 1 receptor genes
    Hypertension research
    
    A. Sugawara et al., "Differential effects among thiazolidinediones on the transcription of thromboxane receptor and angiotensin II type 1 receptor genes", HYPERTENS R, 24(3), 2001, pp. 229-233
22. Mohan, IK; Das, UN
    Prevention of chemically induced diabetes mellitus in experimental animalsby polyunsaturated fatty acids
    NUTRITION
    
    I.K. Mohan e U.N. Das, "Prevention of chemically induced diabetes mellitus in experimental animalsby polyunsaturated fatty acids", NUTRITION, 17(2), 2001, pp. 126-151
23. Holstad, M; Sandler, S
    A transcriptional inhibitor of TNF-alpha prevents diabetes induced by multiple low-dose streptozotocin injections in mice
    JOURNAL OF AUTOIMMUNITY
    
    M. Holstad e S. Sandler, "A transcriptional inhibitor of TNF-alpha prevents diabetes induced by multiple low-dose streptozotocin injections in mice", J AUTOIMMUN, 16(4), 2001, pp. 441-447
24. Smith, U; Gogg, S; Johansson, A; Olausson, T; Rotter, V; Svalstedt, B
    Thiazolidinediones (PPAR gamma agonists) but not PPAR alpha agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes
    FASEB JOURNAL
    
    U. Smith et al., "Thiazolidinediones (PPAR gamma agonists) but not PPAR alpha agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes", FASEB J, 15(1), 2001, pp. 215-220
25. Chvojkova, S; Kazdova, L; Divisova, J
    A comparison of the effects of troglitazone and vitamin E on the fatty acid composition of serum phospholipids in an experimental model of insulin resistance
    PHYSIOLOGICAL RESEARCH
    
    S. Chvojkova et al., "A comparison of the effects of troglitazone and vitamin E on the fatty acid composition of serum phospholipids in an experimental model of insulin resistance", PHYSL RES, 50(3), 2001, pp. 261-266
26. Lestavel, S; Chinetti, G; Bocher, V; Fruchart, JC; Clavey, V; Staels, B
    Peroxisome proliferator-activated receptors in human atherosclerosis
    M S-MEDECINE SCIENCES
    
    S. Lestavel et al., "Peroxisome proliferator-activated receptors in human atherosclerosis", M S-MED SCI, 17(5), 2001, pp. 637-642
27. Grimaldi, A; Hartemann-Heurtier, A
    Type 2 diabetes mellitus: choosing the right therapeutic strategy
    PRESSE MEDICALE
    
    A. Grimaldi e A. Hartemann-Heurtier, "Type 2 diabetes mellitus: choosing the right therapeutic strategy", PRESSE MED, 30(6), 2001, pp. 288-297
28. Lehtovirta, M; Forsen, B; Gullstrom, M; Haggblom, M; Eriksson, JG; Taskinen, MR; Groop, L
    Metabolic effects of metformin in patients with impaired glucose tolerance
    DIABETIC MEDICINE
    
    M. Lehtovirta et al., "Metabolic effects of metformin in patients with impaired glucose tolerance", DIABET MED, 18(7), 2001, pp. 578-583
29. Nicolaides, E; Symillides, M; Dressman, JB; Reppas, C
    Biorelevant dissolution testing to predict the plasma profile of lipophilic drugs after oral administration
    PHARMACEUTICAL RESEARCH
    
    E. Nicolaides et al., "Biorelevant dissolution testing to predict the plasma profile of lipophilic drugs after oral administration", PHARM RES, 18(3), 2001, pp. 380-388
30. Zhang, B; Shiomi, M; Tanaka, H; Mei, J; Fan, P; Tsujita, Y; Horikoshi, H; Saku, K
    Effects of high-dose troglitazone on insulin sensitivity and beta-cell function in watanabe heritable hyperlipidemic rabbits
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
    
    B. Zhang et al., "Effects of high-dose troglitazone on insulin sensitivity and beta-cell function in watanabe heritable hyperlipidemic rabbits", EUR J DRUG, 26(3), 2001, pp. 185-192
31. Guan, YF; Zhang, YH; Schneider, A; Davis, L; Breyer, RM; Breyer, MD
    Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
    
    Y.F. Guan et al., "Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature", AM J P-REN, 281(6), 2001, pp. F1036-F1046
32. Haskins, JR; Rowse, P; Rahbari, R; de la Iglesia, FA
    Thiazolidinedione toxicity to isolated hepatocytes revealed by coherent multiprobe fluorescence microscopy and correlated with multiparameter flow cytometry of peripheral leukocytes
    ARCHIVES OF TOXICOLOGY
    
    J.R. Haskins et al., "Thiazolidinedione toxicity to isolated hepatocytes revealed by coherent multiprobe fluorescence microscopy and correlated with multiparameter flow cytometry of peripheral leukocytes", ARCH TOXIC, 75(7), 2001, pp. 425-438
33. Farrar, NS; Chambers, NJ; Carlsson, AR; Denyer, G; Johnston, GAR
    Effect of a series of novel sulphonylthioureas on glucose tolerance in theobese fa/fa Zucker rat
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    
    N.S. Farrar et al., "Effect of a series of novel sulphonylthioureas on glucose tolerance in theobese fa/fa Zucker rat", CLIN EXP PH, 28(5-6), 2001, pp. 386-391
34. Mu, YM; Yanase, T; Nishi, Y; Takayanagi, R; Goto, K; Nawata, H
    Combined treatment with specific ligands for PPAR gamma : RXR nuclear receptor system markedly inhibits the expression of cytochrome P450arom in human granulosa cancer cells
    MOLECULAR AND CELLULAR ENDOCRINOLOGY
    
    Y.M. Mu et al., "Combined treatment with specific ligands for PPAR gamma : RXR nuclear receptor system markedly inhibits the expression of cytochrome P450arom in human granulosa cancer cells", MOL C ENDOC, 181(1-2), 2001, pp. 239-248
35. Toprak, S; Yonem, A; Cakir, B; Guler, S; Azal, O; Ozata, M; Corakci, A
    Insulin resistance in nonobese patients with polycystic ovary syndrome
    HORMONE RESEARCH
    
    S. Toprak et al., "Insulin resistance in nonobese patients with polycystic ovary syndrome", HORMONE RES, 55(2), 2001, pp. 65-70
36. Vander Lugt, JT; Gomez-Marquez, J; Caldon, J; Louters, LL
    Combined effects of troglitazone and muscle contraction on insulin sensitization in Balb-c mouse muscle
    BIOCHIMIE
    
    J.T. Vander Lugt et al., "Combined effects of troglitazone and muscle contraction on insulin sensitization in Balb-c mouse muscle", BIOCHIMIE, 83(5), 2001, pp. 445-451
37. Funk, C; Pantze, M; Jehle, L; Ponelle, C; Scheuermann, G; Lazendic, M; Gasser, R
    Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile salt export pump (Bsep) by troglitazone and troglitazone sulfate
    TOXICOLOGY
    
    C. Funk et al., "Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile salt export pump (Bsep) by troglitazone and troglitazone sulfate", TOXICOLOGY, 167(1), 2001, pp. 83-98
38. St Peter, JV; Neafus, KL; Khan, MA; Vessey, JT; Lockheart, MSK
    Factors associated with the risk of liver enzyme elevation in patients with type 2 diabetes treated with a thiazolidinedione
    PHARMACOTHERAPY
    
    J.V. St Peter et al., "Factors associated with the risk of liver enzyme elevation in patients with type 2 diabetes treated with a thiazolidinedione", PHARMACOTHE, 21(2), 2001, pp. 183-188
39. Bissell, DM; Gores, GJ; Laskin, DL; Hoofnagle, JH
    Drug-induced liver injury: Mechanisms and test systems
    HEPATOLOGY
    
    D.M. Bissell et al., "Drug-induced liver injury: Mechanisms and test systems", HEPATOLOGY, 33(4), 2001, pp. 1009
40. Ng, EHY; Wat, NMS; Ho, PC
    Effects of metformin on ovulation rate, hormonal and metabolic profiles inwomen with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial
    HUMAN REPRODUCTION
    
    E.H.Y. Ng et al., "Effects of metformin on ovulation rate, hormonal and metabolic profiles inwomen with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial", HUM REPR, 16(8), 2001, pp. 1625-1631
41. Marino, G; Lewis, JH
    Drug-induced liver disease
    CURRENT OPINION IN GASTROENTEROLOGY
    
    G. Marino e J.H. Lewis, "Drug-induced liver disease", CURR OPIN G, 17(3), 2001, pp. 232-241
42. Pedraza, N; Solanes, G; Iglesias, R; Vazquez, M; Giralt, M; Villarroya, F
    Differential regulation of expression of genes encoding uncoupling proteins 2 and 3 in brown adipose tissue during lactation in mice
    BIOCHEMICAL JOURNAL
    
    N. Pedraza et al., "Differential regulation of expression of genes encoding uncoupling proteins 2 and 3 in brown adipose tissue during lactation in mice", BIOCHEM J, 355, 2001, pp. 105-111
43. Yoshida, K; Kohzuki, M; Xu, HL; Wu, XM; Kamimoto, M; Sato, T
    Effects of troglitazone and temocapril in spontaneously hypertensive rats with chronic renal failure
    JOURNAL OF HYPERTENSION
    
    K. Yoshida et al., "Effects of troglitazone and temocapril in spontaneously hypertensive rats with chronic renal failure", J HYPERTENS, 19(3), 2001, pp. 503-510
44. Harrigan, RA; Nathan, MS; Beattie, P
    Oral agents for the treatment of type 2 diabetes mellitus: Pharmacology, toxicity, and treatment
    ANNALS OF EMERGENCY MEDICINE
    
    R.A. Harrigan et al., "Oral agents for the treatment of type 2 diabetes mellitus: Pharmacology, toxicity, and treatment", ANN EMERG M, 38(1), 2001, pp. 68-78
45. Nicholas, SB; Kawano, Y; Wakino, S; Collins, AR; Hsueh, WA
    Expression and function of peroxisome proliferator-activated receptor-gamma in mesangial cells
    HYPERTENSION
    
    S.B. Nicholas et al., "Expression and function of peroxisome proliferator-activated receptor-gamma in mesangial cells", HYPERTENSIO, 37(2), 2001, pp. 722-727
46. Cowan, SM; Bunch, SE
    Oral antidiabetic drugs for cats
    COMPENDIUM ON CONTINUING EDUCATION FOR THE PRACTICING VETERINARIAN
    
    S.M. Cowan e S.E. Bunch, "Oral antidiabetic drugs for cats", COMP CONT E, 23(7), 2001, pp. 633-642
47. Hupfeld, CJ; Weiss, RH
    TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p21 and p27
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    
    C.J. Hupfeld e R.H. Weiss, "TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p21 and p27", AM J P-ENDO, 281(2), 2001, pp. E207-E216
48. Tornvig, L; Mosekilde, L; Justesen, J; Falk, E; Kassem, M
    Troglitazone treatment increases bone marrow adipose tissue volume but does not affect trabecular bone volume in mice
    CALCIFIED TISSUE INTERNATIONAL
    
    L. Tornvig et al., "Troglitazone treatment increases bone marrow adipose tissue volume but does not affect trabecular bone volume in mice", CALCIF TIS, 69(1), 2001, pp. 46-50
49. Bedoucha, M; Atzpodien, E; Boelsterli, UA
    Diabetic KKA(y) mice exhibit increased hepatic PPAR gamma 1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones
    JOURNAL OF HEPATOLOGY
    
    M. Bedoucha et al., "Diabetic KKA(y) mice exhibit increased hepatic PPAR gamma 1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones", J HEPATOL, 35(1), 2001, pp. 17-23
50. Nakamura, T; Funahashi, T; Yamashita, S; Nishida, M; Nishida, Y; Takahashi, M; Hotta, K; Kuriyama, H; Kihara, S; Ohuchi, N; Nishimura, T; Kishino, B; Ishikawa, K; Kawamoto, T; Tokunaga, K; Nakagawa, C; Mineo, I; Watanabe, F; Tarui, S; Matsuzawa, Y
    Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation - double-blind placebo-controlled trial
    DIABETES RESEARCH AND CLINICAL PRACTICE
    
    T. Nakamura et al., "Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation - double-blind placebo-controlled trial", DIABET RE C, 54(3), 2001, pp. 181-190
51. Maruyama, S; Yanagisawa, K; Kanamuro, R; Teno, S; Iwamoto, Y
    Serum leptin level as an indicator to predict the clinical efficacy of troglitazone in patients with type 2 diabetes mellitus
    DIABETES RESEARCH AND CLINICAL PRACTICE
    
    S. Maruyama et al., "Serum leptin level as an indicator to predict the clinical efficacy of troglitazone in patients with type 2 diabetes mellitus", DIABET RE C, 53(3), 2001, pp. 161-164
52. Hirayama, H; Sugano, M; Abe, N; Yonemoch, H; Makino, N
    Troglitazone, an antidiabetic drug, improves left ventricular mass and diastolic function in nonmotensive diabetic patients
    INTERNATIONAL JOURNAL OF CARDIOLOGY
    
    H. Hirayama et al., "Troglitazone, an antidiabetic drug, improves left ventricular mass and diastolic function in nonmotensive diabetic patients", INT J CARD, 77(1), 2001, pp. 75-79
53. Niino, M; Iwabuchi, K; Kikuchi, S; Ato, M; Morohashi, T; Ogata, A; Tashiro, K; Onoe, K
    Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-gamma
    JOURNAL OF NEUROIMMUNOLOGY
    
    M. Niino et al., "Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-gamma", J NEUROIMM, 116(1), 2001, pp. 40-48
54. Caldwell, SH; Hespenheide, ER; Von Borstel, RW
    Myositis, microvesicular hepatitis, and progression to cirrhosis from troglitazone added to simavastatin
    DIGESTIVE DISEASES AND SCIENCES
    
    S.H. Caldwell et al., "Myositis, microvesicular hepatitis, and progression to cirrhosis from troglitazone added to simavastatin", DIG DIS SCI, 46(2), 2001, pp. 376-378
55. Yokoyama, I; Yonekura, K; Moritan, T; Tateno, M; Momose, T; Ohtomo, K; Inoue, Y; Nagai, R
    Troglitazone improves whole-body insulin resistance and skeletal muscle glucose use in type II diabetic patients
    JOURNAL OF NUCLEAR MEDICINE
    
    I. Yokoyama et al., "Troglitazone improves whole-body insulin resistance and skeletal muscle glucose use in type II diabetic patients", J NUCL MED, 42(7), 2001, pp. 1005-1010
56. Tsuji, T; Mizushige, K; Noma, T; Murakami, K; Ohmori, K; Miyatake, A; Kohno, M
    Pioglitazone improves left ventricular diastolic function and decreases collagen accumulation in prediabetic stage of a type II diabetic rat
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    
    T. Tsuji et al., "Pioglitazone improves left ventricular diastolic function and decreases collagen accumulation in prediabetic stage of a type II diabetic rat", J CARDIO PH, 38(6), 2001, pp. 868-874
57. Raskin, P; Rendell, M; Riddle, MC; Dole, JF; Freed, MI; Rosenstock, J
    A randomized trial of rosiglitazone therapy in patients with inadequately controlled insulin-treated type 2 diabetes
    DIABETES CARE
    
    P. Raskin et al., "A randomized trial of rosiglitazone therapy in patients with inadequately controlled insulin-treated type 2 diabetes", DIABET CARE, 24(7), 2001, pp. 1226-1232
58. Miyazaki, Y; Mahankali, A; Matsuda, M; Glass, L; Mahankali, S; Ferrannini, E; Cusi, K; Mandarino, LJ; DeFronzo, RA
    Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone
    DIABETES CARE
    
    Y. Miyazaki et al., "Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone", DIABET CARE, 24(4), 2001, pp. 710-719
59. Phillips, LS; Grunberger, G; Miller, E; Patwardhan, R; Rappaport, EB; Salzman, A
    Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes
    DIABETES CARE
    
    L.S. Phillips et al., "Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes", DIABET CARE, 24(2), 2001, pp. 308-315
60. Katsuki, A; Sumida, Y; Gabazza, EC; Murashima, S; Furuta, M; Araki-Sasaki, R; Hori, Y; Yano, Y; Adachi, Y
    Homeostasis model assessment is a reliable indicator of insulin resistanceduring follow-up of patients with type 2 diabetes
    DIABETES CARE
    
    A. Katsuki et al., "Homeostasis model assessment is a reliable indicator of insulin resistanceduring follow-up of patients with type 2 diabetes", DIABET CARE, 24(2), 2001, pp. 362-365
61. Hsueh, WA; Jackson, S; Law, RE
    Control of vascular cell proliferation and migration by PPAR-gamma - A newapproach to the macrovascular complications of diabetes
    DIABETES CARE
    
    W.A. Hsueh et al., "Control of vascular cell proliferation and migration by PPAR-gamma - A newapproach to the macrovascular complications of diabetes", DIABET CARE, 24(2), 2001, pp. 392-397
62. Gale, EAM
    Lessons from the glitazones: a story of drug development
    LANCET
    
    E.A.M. Gale, "Lessons from the glitazones: a story of drug development", LANCET, 357(9271), 2001, pp. 1870-1875
63. Kaplowitz, N
    Drug-induced liver disorders - Implications for drug development and regulation
    DRUG SAFETY
    
    N. Kaplowitz, "Drug-induced liver disorders - Implications for drug development and regulation", DRUG SAFETY, 24(7), 2001, pp. 483-490
64. Inglis, AML; Miller, AK; Culkin, KT; Finnerty, D; Patterson, SD; Jorkasky, DK; Freed, MI
    Lack of effect of rosiglitazone on the pharmacokinetics of oral contraceptives in healthy female volunteers
    JOURNAL OF CLINICAL PHARMACOLOGY
    
    A.M.L. Inglis et al., "Lack of effect of rosiglitazone on the pharmacokinetics of oral contraceptives in healthy female volunteers", J CLIN PHAR, 41(6), 2001, pp. 683-690
65. Lebovitz, HE; Banerji, MA
    Insulin resistance and its treatment by thiazolidinediones
    RECENT PROGRESS IN HORMONE RESEARCH, VOL 56
    
    H.E. Lebovitz e M.A. Banerji, "Insulin resistance and its treatment by thiazolidinediones", REC PROG H, 56, 2001, pp. 265-294
66. Sekiya, M; Suzuki, J; Watanabe, K; Funada, J; Otani, T; Akutsu, H
    Beneficial effect of troglitazone, an insulin-sensitizing antidiabetic agent, on coronary circulation in patients with non-insulin-dependent diabetesmellitus
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION
    
    M. Sekiya et al., "Beneficial effect of troglitazone, an insulin-sensitizing antidiabetic agent, on coronary circulation in patients with non-insulin-dependent diabetesmellitus", JPN CIRC J, 65(6), 2001, pp. 487-490
67. Masuzaki, H; Paterson, J; Shinyama, H; Morton, NM; Mullins, JJ; Seckl, JR; Flier, JS
    A transgenic model of visceral obesity and the metabolic syndrome
    SCIENCE
    
    H. Masuzaki et al., "A transgenic model of visceral obesity and the metabolic syndrome", SCIENCE, 294(5549), 2001, pp. 2166-2170
68. Ito, M; Yamamoto, K; Sato, H; Fujiyama, Y; Bamba, T
    Inhibitory effect of troglitazone on glucuronidation catalyzed by human uridine diphosphate-glucuronosyltransferase 1A6
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    
    M. Ito et al., "Inhibitory effect of troglitazone on glucuronidation catalyzed by human uridine diphosphate-glucuronosyltransferase 1A6", EUR J CL PH, 56(12), 2001, pp. 893-895
69. Kubota, K; Kawabe, E; Hinotsu, S; Hamada, C; Ohashi, Y; Kurokawa, K
    Pilot study of prescription-event monitoring in Japan comparing troglitazone with alternative oral hypoglycemics
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    
    K. Kubota et al., "Pilot study of prescription-event monitoring in Japan comparing troglitazone with alternative oral hypoglycemics", EUR J CL PH, 56(11), 2001, pp. 831-838
70. Gouni-Berthold, I; Berthold, HK; Weber, AA; Ko, Y; Seul, C; Vetter, H; Sachinidis, A
    Troglitazone and rosiglitazone induce apoptosis of vascular smooth muscle cells through an extracellular signal-regulated kinase-independent pathway
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    
    I. Gouni-Berthold et al., "Troglitazone and rosiglitazone induce apoptosis of vascular smooth muscle cells through an extracellular signal-regulated kinase-independent pathway", N-S ARCH PH, 363(2), 2001, pp. 215-221
71. Igarashi, M; Hirata, A; Yamaguchi, H; Tsuchiya, H; Ohnuma, H; Tominaga, M; Daimon, M; Kato, T
    Characterization of an inhibitory effect of pioglitazone on balloon-injured vascular smooth muscle cell growth
    METABOLISM-CLINICAL AND EXPERIMENTAL
    
    M. Igarashi et al., "Characterization of an inhibitory effect of pioglitazone on balloon-injured vascular smooth muscle cell growth", METABOLISM, 50(8), 2001, pp. 955-962
72. Ebeling, P; Teppo, AM; Koistinen, HA; Koivisto, VA
    Concentration of the complement activation product, acylation-stimulating protein, is related to C-reactive protein in patients with type 2 diabetes
    METABOLISM-CLINICAL AND EXPERIMENTAL
    
    P. Ebeling et al., "Concentration of the complement activation product, acylation-stimulating protein, is related to C-reactive protein in patients with type 2 diabetes", METABOLISM, 50(3), 2001, pp. 283-287
73. Suzuki, Y; Urano, T; Ihara, H; Nakajima, T; Nagai, N; Takada, Y; Taminato, T; Takada, A
    Bezafibrate attenuates the overexpression of plasminogen activator inhibitor-1 messenger RNA by a combination of mono-unsaturated fatty acid and insulin in HepG2 cells
    LIFE SCIENCES
    
    Y. Suzuki et al., "Bezafibrate attenuates the overexpression of plasminogen activator inhibitor-1 messenger RNA by a combination of mono-unsaturated fatty acid and insulin in HepG2 cells", LIFE SCI, 68(16), 2001, pp. 1827-1837
74. Toyoda, Y; Tsuchida, A; Iwami, E; Miwa, I
    Toxic effect of troglitazone on cultured rat hepatocytes
    LIFE SCIENCES
    
    Y. Toyoda et al., "Toxic effect of troglitazone on cultured rat hepatocytes", LIFE SCI, 68(16), 2001, pp. 1867-1876
75. Koshiyama, H; Shimono, D; Kuwamura, N; Minamikawa, J; Nakamura, Y
    Inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes
    JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    
    H. Koshiyama et al., "Inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes", J CLIN END, 86(7), 2001, pp. 3452-3456
76. Azziz, R; Ehrmann, D; Legro, RS; Whitcomb, RW; Hanley, R; Fereshetian, AG; O'Keefe, M; Ghazzi, MN
    Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial
    JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    
    R. Azziz et al., "Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial", J CLIN END, 86(4), 2001, pp. 1626-1632
77. Lebovitz, HE; Dole, JF; Patwardhan, R; Rappaport, EB; Freed, MI
    Rosiglitazone monotherapy is effective in patients with type 2 diabetes
    JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    
    H.E. Lebovitz et al., "Rosiglitazone monotherapy is effective in patients with type 2 diabetes", J CLIN END, 86(1), 2001, pp. 280-288
78. Kim, JH; Lewin, TM; Coleman, RA
    Expression and characterization of recombinant rat acyl-CoA synthetases 1,4, and 5 - Selective inhibition by triacsin C and thiazolidinediones
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    J.H. Kim et al., "Expression and characterization of recombinant rat acyl-CoA synthetases 1,4, and 5 - Selective inhibition by triacsin C and thiazolidinediones", J BIOL CHEM, 276(27), 2001, pp. 24667-24673
79. Arlt, W; Auchus, RJ; Miller, WL
    Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3 beta-hydroxysteroid dehydrogenase
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    W. Arlt et al., "Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3 beta-hydroxysteroid dehydrogenase", J BIOL CHEM, 276(20), 2001, pp. 16767-16771
80. Fukunaga, Y; Itoh, H; Doi, K; Tanaka, T; Yamashita, J; Chun, TH; Inoue, M; Masatsugu, K; Sawada, N; Saito, T; Hosoda, K; Kook, H; Ueda, M; Nakao, K
    Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides
    ATHEROSCLEROSIS
    
    Y. Fukunaga et al., "Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides", ATHEROSCLER, 158(1), 2001, pp. 113-119
81. Janka, HU
    Glitazone - Profile of a new class of substances
    INTERNIST
    
    H.U. Janka, "Glitazone - Profile of a new class of substances", INTERNIST, 42(4), 2001, pp. 587
82. Itami, A; Watanabe, G; Shimada, Y; Hashimoto, Y; Kawamura, J; Kato, M; Hosotani, R; Imamura, M
    Ligands for peroxisome proliferator-activated receptor gamma inhibit growth of pancreatic cancers both in vitro and in vivo
    INTERNATIONAL JOURNAL OF CANCER
    
    A. Itami et al., "Ligands for peroxisome proliferator-activated receptor gamma inhibit growth of pancreatic cancers both in vitro and in vivo", INT J CANC, 94(3), 2001, pp. 370-376
83. Schneider, MB; Matsuzaki, H; Haorah, J; Ulrich, A; Standop, J; Ding, XZ; Adrian, TE; Pour, PM
    Prevention of pancreatic cancer induction in hamsters by metformin
    GASTROENTEROLOGY
    
    M.B. Schneider et al., "Prevention of pancreatic cancer induction in hamsters by metformin", GASTROENTY, 120(5), 2001, pp. 1263-1270
84. Vandermolen, DT; Ratts, VS; Evans, WS; Stovall, DW; Kauma, SW; Nestler, JE
    Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone
    FERTILITY AND STERILITY
    
    D.T. Vandermolen et al., "Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone", FERT STERIL, 75(2), 2001, pp. 310-315
85. Naderali, EK; Pickavance, LC; Wilding, JPH; Doyle, PJ; Wiliams, G
    Troglitazone corrects metabolic changes but not vascular dysfunction in dietary-obese rats
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    E.K. Naderali et al., "Troglitazone corrects metabolic changes but not vascular dysfunction in dietary-obese rats", EUR J PHARM, 416(1-2), 2001, pp. 133-139
86. Camp, HS; Chaudhry, A; Leff, T
    A novel potent antagonist of peroxisome proliferator-activated receptor gamma blocks adipocyte differentiation but does not revert the phenotype of terminally differentiated adipocytes
    ENDOCRINOLOGY
    
    H.S. Camp et al., "A novel potent antagonist of peroxisome proliferator-activated receptor gamma blocks adipocyte differentiation but does not revert the phenotype of terminally differentiated adipocytes", ENDOCRINOL, 142(7), 2001, pp. 3207-3213
87. Way, JM; Harrington, WW; Brown, KK; Gottschalk, WK; Sundseth, SS; Mansfield, TA; Ramachandran, RK; Willson, TM; Kliewer, SA
    Comprehensive messenger ribonucleic acid profiling reveals that peroxisomeproliferator-activated receptor gamma activation has coordinate effects ongene expression in multiple insulin-sensitive tissues
    ENDOCRINOLOGY
    
    J.M. Way et al., "Comprehensive messenger ribonucleic acid profiling reveals that peroxisomeproliferator-activated receptor gamma activation has coordinate effects ongene expression in multiple insulin-sensitive tissues", ENDOCRINOL, 142(3), 2001, pp. 1269-1277
88. Komar, CM; Braissant, O; Wahli, W; Curry, TE
    Expression and localization of PPARs in the rat ovary during follicular development and the periovulatory period
    ENDOCRINOLOGY
    
    C.M. Komar et al., "Expression and localization of PPARs in the rat ovary during follicular development and the periovulatory period", ENDOCRINOL, 142(11), 2001, pp. 4831-4838
89. Corpe, C; Sreenan, S; Burant, C
    Effects of type-2 diabetes and troglitazone on the expression patterns of small intestinal sugar transporters and PPAR-gamma in the Zucker diabetic fatty rat
    DIGESTION
    
    C. Corpe et al., "Effects of type-2 diabetes and troglitazone on the expression patterns of small intestinal sugar transporters and PPAR-gamma in the Zucker diabetic fatty rat", DIGESTION, 63(2), 2001, pp. 116-123
90. Cha, BS; Ciaraldi, TP; Carter, L; Nikoulina, SE; Mudaliar, S; Mukherjee, R; Paterniti, JR; Henry, RR
    Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle
    DIABETOLOGIA
    
    B.S. Cha et al., "Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle", DIABETOLOG, 44(4), 2001, pp. 444-452
91. Rosenstock, M; Greenberg, AS; Rudich, A
    Distinct long-term regulation of glycerol and non-esterified fatty acid release by insulin and TNF-alpha in 3T3-L1 adipocytes
    DIABETOLOGIA
    
    M. Rosenstock et al., "Distinct long-term regulation of glycerol and non-esterified fatty acid release by insulin and TNF-alpha in 3T3-L1 adipocytes", DIABETOLOG, 44(1), 2001, pp. 55-62
92. de Souza, CJ; Eckhardt, M; Gagen, K; Dong, M; Chen, W; Laurent, D; Burkey, BF
    Effects of pioglitazone on adipose tissue remodeling within the setting ofobesity and insulin resistance
    DIABETES
    
    C.J. de Souza et al., "Effects of pioglitazone on adipose tissue remodeling within the setting ofobesity and insulin resistance", DIABETES, 50(8), 2001, pp. 1863-1871
93. Brunmair, B; Gras, F; Neschen, S; Roden, M; Wagner, L; Waldhausl, W; Furnsinn, C
    Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptor-gamma-mediated changes in gene expression
    DIABETES
    
    B. Brunmair et al., "Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptor-gamma-mediated changes in gene expression", DIABETES, 50(10), 2001, pp. 2309-2315
94. Yue, TL; Chen, J; Bao, WK; Narayanan, PK; Bril, A; Jiang, W; Lysko, PG; Gu, JL; Boyce, R; Zimmerman, DM; Hart, TK; Buckingham, RE; Ohlstein, EH
    In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone
    CIRCULATION
    
    T.L. Yue et al., "In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone", CIRCULATION, 104(21), 2001, pp. 2588-2594
95. Yamamoto, K; Ohki, R; Lee, RT; Ikeda, U; Shimada, K
    Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes
    CIRCULATION
    
    K. Yamamoto et al., "Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes", CIRCULATION, 104(14), 2001, pp. 1670-1675
96. Sobel, BE
    Acceleration of restenosis by diabetes - Pathogenetic implications
    CIRCULATION
    
    B.E. Sobel, "Acceleration of restenosis by diabetes - Pathogenetic implications", CIRCULATION, 103(9), 2001, pp. 1185-1187
97. Ulrich, RG; Bacon, JA; Brass, EP; Cramer, CT; Petrella, DK; Sun, EL
    Metabolic, idiosyncratic toxicity of drugs: overview of the hepatic toxicity induced by the anxiolytic, panadiplon
    CHEMICO-BIOLOGICAL INTERACTIONS
    
    R.G. Ulrich et al., "Metabolic, idiosyncratic toxicity of drugs: overview of the hepatic toxicity induced by the anxiolytic, panadiplon", CHEM-BIO IN, 134(3), 2001, pp. 251-270
98. Palakurthi, SS; Aktas, H; Grubissich, LM; Mortensen, RM; Halperin, JA
    Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor gamma and mediated by inhibition of translation initiation
    CANCER RESEARCH
    
    S.S. Palakurthi et al., "Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor gamma and mediated by inhibition of translation initiation", CANCER RES, 61(16), 2001, pp. 6213-6218
99. Furuse, Y; Ogino, K; Shimoyama, M; Sasaki, N; Hisatome, I
    Ca2+-sensitizing effect is involved in the positive inotropic effect of troglitazone
    BRITISH JOURNAL OF PHARMACOLOGY
    
    Y. Furuse et al., "Ca2+-sensitizing effect is involved in the positive inotropic effect of troglitazone", BR J PHARM, 133(8), 2001, pp. 1307-1313
100. Davies, GF; Khandelwal, RL; Wu, LY; Juurlink, BHJ; Roesler, WJ
     Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression bytroglitazone: a peroxisome proliferator-activated receptor-gamma (PPAR gamma)-independent, antioxidant-related mechanism
     BIOCHEMICAL PHARMACOLOGY
     
     G.F. Davies et al., "Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression bytroglitazone: a peroxisome proliferator-activated receptor-gamma (PPAR gamma)-independent, antioxidant-related mechanism", BIOCH PHARM, 62(8), 2001, pp. 1071-1079